BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TRD
30 results:

  • 1. Outcomes of adolescents with acute lymphoblastic leukaemia.
    Feng J; Cheng FWT; Chiang AKS; Lam GKS; Chow TTW; Ha SY; Luk CW; Li CH; Ling SC; Yau PW; Ho KKH; Leung AWK; Chan NPH; Ng MHL; Li CK
    Hong Kong Med J; 2022 Jun; 28(3):204-214. PubMed ID: 35697524
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic leukemia.
    Villarese P; Abdo C; Bertrand M; Thonier F; Giraud M; Salson M; Macintyre E
    Methods Mol Biol; 2022; 2453():43-59. PubMed ID: 35622319
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes.
    Gozlan EC; Chobrutskiy BI; Blanck G
    Int J Lab Hematol; 2022 Oct; 44(5):883-891. PubMed ID: 35527672
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Influence of the disordered domain structure of MeCP2 on its structural stability and dsDNA interaction.
    Ortega-Alarcon D; Claveria-Gimeno R; Vega S; Jorge-Torres OC; Esteller M; Abian O; Velazquez-Campoy A
    Int J Biol Macromol; 2021 Apr; 175():58-66. PubMed ID: 33548325
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2.
    Ortega-Alarcon D; Claveria-Gimeno R; Vega S; Jorge-Torres OC; Esteller M; Abian O; Velazquez-Campoy A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33182787
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation.
    Anteneh H; Fang J; Song J
    Nat Commun; 2020 May; 11(1):2294. PubMed ID: 32385248
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chromosome Translocation t(14;21)(q11;q22) Activates Both
    Panagopoulos I; Gorunova L; Johannsdottir IMR; Andersen K; Holth A; Beiske K; Heim S
    Cancer Genomics Proteomics; 2020; 17(1):41-48. PubMed ID: 31882550
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selection.
    Theunissen PMJ; de Bie M; van Zessen D; de Haas V; Stubbs AP; van der Velden VHJ
    Leuk Res; 2019 Jan; 76():98-104. PubMed ID: 30389174
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
    Sun YN; Hu YX; Gao L; Xiao PF; Lu J; Wu SY; Wang M; Shao XJ; Zhou CY; Ling J; Li JQ; Pan J; Gao J; Hu SY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6020-6029. PubMed ID: 30280786
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging.
    Kallemeijn MJ; Kavelaars FG; van der Klift MY; Wolvers-Tettero ILM; Valk PJM; van Dongen JJM; Langerak AW
    Front Immunol; 2018; 9():448. PubMed ID: 29559980
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones.
    Theunissen PMJ; van Zessen D; Stubbs AP; Faham M; Zwaan CM; van Dongen JJM; Van Der Velden VHJ
    Haematologica; 2017 Nov; 102(11):1869-1877. PubMed ID: 28860343
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
    Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multi-loci diagnosis of acute lymphoblastic leukaemia with high-throughput sequencing and bioinformatics analysis.
    Ferret Y; Caillault A; Sebda S; Duez M; Grardel N; Duployez N; Villenet C; Figeac M; Preudhomme C; Salson M; Giraud M
    Br J Haematol; 2016 May; 173(3):413-20. PubMed ID: 26898266
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
    Tomizawa D; Watanabe T; Hanada R; Horibe K; Horikoshi Y; Iwamoto S; Kinoshita A; Moritake H; Nakayama H; Shimada A; Taga T; Takahashi H; Tawa A; Terui K; Hori H; Kawano Y; Kikuta A; Manabe A; Adachi S
    Int J Hematol; 2015 Sep; 102(3):318-26. PubMed ID: 26126642
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia.
    Tota G; Coccaro N; Zagaria A; Anelli L; Casieri P; Cellamare A; Minervini A; Minervini CF; Brunetti C; Impera L; Carluccio P; Cumbo C; Specchia G; Albano F
    BMC Cancer; 2014 Dec; 14():963. PubMed ID: 25515027
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
    Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
    Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
    Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
    Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
    Br J Haematol; 2011 Mar; 152(5):623-30. PubMed ID: 21241281
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
    Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
    Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.